If you have ever been part of a GMP inspection — at an HPRA site visit, an EMA joint audit, or an FDA pre-approval inspection (PAI) — you will know that document control findings are among the most frequently cited non-conformances. Of those, the most common sub-category is preventable: documents in use that are not clearly marked with their current approval status.
This guide explains why document status stamps are a regulatory obligation, which stamps apply to which document types, and how Irish pharma, MedTech, and life science teams can apply them digitally — without uploading sensitive documents to any cloud service.
What Is GMP Document Stamping?
GMP document stamping is the practice of visibly marking a controlled pharmaceutical or medical device document with its current lifecycle status. The most common stamps are:
- APPROVED — document has been reviewed, approved, and is the current authorised version for use.
- CONTROLLED COPY — an official, tracked copy of an approved document; not to be reproduced without authorisation.
- DRAFT — a working version under development; not authorised for use in GMP operations.
- SUPERSEDED — a previous version that has been replaced; must be withdrawn from use.
- FOR REVIEW — circulated for SME, QA, or regulatory review prior to approval.
- VOID — a document that has been cancelled and must not be used.
- CONFIDENTIAL — restricted distribution; not for sharing outside authorised personnel.
These markings are not administrative preferences. They are requirements embedded in multiple regulatory frameworks that govern the Irish pharmaceutical and medical device industry.
The Regulatory Framework
EU GMP Annex 1 — 2022 Revision
The revised Annex 1 (Manufacture of Sterile Medicinal Products), which came into full effect in August 2023, strengthens the requirement for robust document management systems. Section 4 of Annex 1 specifically requires that controlled documents issued to manufacturing personnel be clearly identifiable as approved, current versions. The CONTROLLED COPY stamp convention ensures that if a newer version supersedes the document, the old copy cannot be confused with the current-authorised version.
FDA 21 CFR Part 11 — Electronic Records
For US-regulated facilities and US FDA pre-approval inspections of Irish manufacturing sites, 21 CFR Part 11 governs the integrity of electronic records. A key Part 11 principle is that electronic records must be trustworthy and equivalent to paper records. Document status visibility — whether the document is an approved, current record or a draft — is central to that trust. Tools that process documents entirely client-side (with no cloud upload) remove a common source of Part 11 audit complexity around third-party record storage.
FDA 21 CFR Part 820 — Quality System Regulation
Medical device manufacturers operating under 21 CFR Part 820 (and its successor, the Quality Management System Regulation) are required to maintain document control procedures that ensure only approved, current-revision documents are in use. This applies to design history files, device master records, manufacturing procedures, inspection and test procedures, and quality records. APPROVED and SUPERSEDED stamps are the standard mechanism for making this status immediately visible.
ICH Q10 — Pharmaceutical Quality System
ICH Q10 describes a comprehensive model for an effective pharmaceutical quality system across all stages of the product lifecycle. Document control is one of the four foundational PQS elements specified in ICH Q10. The standard expects that documents be clearly version-controlled and that status visibility be maintained across all lifecycle stages — from clinical development through commercial manufacturing and post-market.
HPRA — Health Products Regulatory Authority, Ireland
HPRA's published GMP inspection findings consistently highlight failures in document management as a recurring observation category. The specific finding pattern is well-documented: documents found in use on the manufacturing floor without clear version or approval status marking; or obsolete documents not withdrawn and still present in the production area. For any Irish-based pharmaceutical, biopharmaceutical, or MedTech manufacturer, consistent and auditable document stamping is the straightforward preventive control.
How to Apply GMP Stamps Digitally — Without Cloud Upload
Traditional stamp tools present a privacy problem for pharmaceutical documents. Uploading a batch record, SOP, or regulatory dossier to a cloud-based stamp tool creates third-party data processing — a potential breach of GDPR Article 25 (Privacy by Design) and the confidentiality commitments embedded in most pharmaceutical QMS policies.
Priya Life Science's GMP Document Stamp Tool resolves this. All stamping runs entirely in your browser using WebAssembly — not a single byte of your document is transmitted to any server. The tool provides 10 GMP-standard stamp presets, draggable positioning, opacity control, and multi-page support. It is free, open source (AGPL-3.0), and requires no account.
For a complete reference on which stamps apply to each document type and how to use the tool, read the full GMP Document Stamping Guide.
Quick Reference: Document Types and Recommended Stamps
- Standard Operating Procedures (SOPs): APPROVED / SUPERSEDED
- Batch Manufacturing Records: CONTROLLED COPY / GMP COMPLIANT
- Validation Protocols (IQ/OQ/PQ): FOR REVIEW / APPROVED
- Regulatory Submissions (HPRA / EMA / FDA): DRAFT / CONTROLLED COPY
- Clinical Trial Documents (IB, ICF, Protocol): CONFIDENTIAL / DRAFT
- Medical Device Technical Files: APPROVED / SUPERSEDED
- CAPA and Deviation Reports: DRAFT / APPROVED
- Quality Agreements: CONTROLLED COPY
